RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Wang, Zheng ^a   Chen, Jinxian ^a   Sun, Jianhua ^a   Cui, Zhe ^a   Wu, Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colon cancer cell SW1116; Eukaryotic initiation factor; Proliferation

Indexed keywords

INITIATION FACTOR 3; LENTIVIRUS VECTOR; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CLONING; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; EIF3B TUMOR GENE; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; RNA INTERFERENCE; TARGET CELL; TUMOR GENE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; COLONIC NEOPLASMS; EUKARYOTIC INITIATION FACTOR-3; GENETIC VECTORS; HUMANS; LENTIVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84862640274     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-119     Document Type: Article

References (24)

1. Johnson LF, Levis R, Abelson HT, Green H, Penman S. Changes in RNA in relation to growth of the fibroblast. IV. Alterations in the production and processing of mRNA and rRNA in resting and growing cells. J Cell Biol 1976, 71:933-938. 10.1083/jcb.71.3.933, 2109779, 993273.
2. Zetterberg A, Larsson O, Wiman KG. What is the restriction point?. Curr Opin Cell Biol 1995, 7:835-842. 10.1016/0955-0674(95)80067-0, 8608014.
3. Donze O, Jagus R, Koromilas AE, Hershey JW, Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3 T3 cells. EMBO J 1995, 14:3828-3834. 394457, 7641700.
4. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 1992, 257:1685-1689. 10.1126/science.1382315, 1382315.
5. Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Wu QL, Fang Y, Sham JS. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res 2004, 64:4197-4200. 10.1158/0008-5472.CAN-03-3747, 15205331.
6. Miluzio A, Beugnet A, Volta V, Biffo S. Eukaryotic initiation factor 6 mediates a continuum between 60S ribosome biogenesis and translation. EMBO Rep 2009, 10:459-465. 10.1038/embor.2009.70, 2680881, 19373251.
7. Gandin V, Miluzio A, Barbieri AM, Beugnet A, Kiyokawa H, Marchisio PC, Biffo S. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 2008, 455:684-688. 10.1038/nature07267, 2753212, 18784653.
8. Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T, Horiuchi S, Shichita M, Yamamoto N, Yamamoto M. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 2000, 20:2489-2494.
9. Eberle J, Krasagakis K, Orfanos CE. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 1997, 71:396-401. 10.1002/(SICI)1097-0215(19970502)71:3<396::AID-IJC16>3.0.CO;2-E, 9139875.
10. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 2004, 10:484-486. 10.1038/nm1042, 15098029.
11. Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SM, Wendel HG, Brem B, Greger H, Lowe SW, Porco JA, Pelletier J. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest 2008, 118:2651-2660. 2423864, 18551192.
12. Bauer C, Diesinger I, Brass N, Steinhart H, Iro H, Meese EU. Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma. Cancer 2001, 92:822-829. 10.1002/1097-0142(20010815)92:4<822::AID-CNCR1388>3.0.CO;2-A, 11550153.
13. Comtesse N, Keller A, Diesinger I, Bauer C, Kayser K, Huwer H, Lenhof HP, Meese E. Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung. Int J Cancer 2007, 120:2538-2544. 10.1002/ijc.22585, 17290396.
14. Elantak L, Wagner S, Herrmannova A, Karaskova M, Rutkai E, Lukavsky PJ, Valasek L. The indispensable N-terminal half of eIF3j/HCR1 cooperates with its structurally conserved binding partner EIF3B/PRT1-RRM and with eIF1A in stringent AUG selection. J Mol Biol 2010, 396:1097-1116. 10.1016/j.jmb.2009.12.047, 2824034, 20060839.
15. Sowa ME, Bennett EJ, Gygi SP, Harper JW. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403. 10.1016/j.cell.2009.04.042, 2716422, 19615732.
16. Zhou M, Sandercock AM, Fraser CS, Ridlova G, Stephens E, Schenauer MR, Yokoi-Fong T, Barsky D, Leary JA, Hershey JW, Doudna JA, Robinson CV. Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc Natl Acad Sci USA 2008, 105:18139-18144. 10.1073/pnas.0801313105, 2587604, 18599441.
17. Dong Z, Liu LH, Han B, Pincheira R, Zhang JT. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 2004, 23:3790-3801. 10.1038/sj.onc.1207465, 15094776.
18. Cappuzzo F, Varella-Garcia M, Rossi E, Gajapathy S, Valente M, Drabkin H, Gemmill R. MYC and EIF3H coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol 2009, 4:472-478. 10.1097/JTO.0b013e31819a5767, 2774779, 19204574.
19. Nupponen NN, Porkka K, Kakkola L, Tanner M, Persson K, Borg A, Isola J, Visakorpi T. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol 1999, 154:1777-1783. 10.1016/S0002-9440(10)65433-8, 1866614, 10362802.
20. Scoles DR, Yong WH, Qin Y, Wawrowsky K, Pulst SM. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c). Hum Mol Genet 2006, 15:1059-1070. 10.1093/hmg/ddl021, 16497727.
21. Mack DL, Boulanger CA, Callahan R, Smith GH. Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis. Breast Cancer Res 2007, 9:R42. 10.1186/bcr1742, 2206715, 17626637.
22. Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Callahan R. Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Oncol 2001, 18:175-179.
23. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, Leong SP, Nelson MA. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 2006, 25:4923-4936. 10.1038/sj.onc.1209495, 16532022.
24. Zhang L, Pan X, Hershey JW. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 2007, 282:5790-5800.